CAFC creates blueprint for early stage challenges to claims brought under doctrine of equivalents
Amgen’s infringement suit was barred by prosecution history estoppel as the Federal Circuit affirmed district court’s Rule 12(b)(6) dismissal
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.